Normal Reference Range for Fecal Calprotectin
The normal reference range for fecal calprotectin is <150 mg/g in adults, with values <50 mg/g considered definitively normal and values between 50-150 mg/g representing an indeterminate zone requiring clinical context. 1
Standard Cutoff Values
The 2023 AGA guidelines establish 150 mg/g as the primary clinical threshold for distinguishing normal from elevated fecal calprotectin in inflammatory bowel disease management 1. This cutoff demonstrates:
- Sensitivity: 71% (95% CI, 62%–78%)
- Specificity: 69% (95% CI, 62%–75%)
for detecting moderate to severe endoscopic inflammation 1
Three-Tiered Interpretation Framework
The evidence supports using three distinct cutoff levels, each with different clinical implications:
<50 mg/g: Most sensitive threshold (78% sensitivity, 57% specificity) - effectively rules out inflammation in asymptomatic patients 1
<150 mg/g: Balanced threshold - the recommended clinical cutoff for decision-making in ulcerative colitis and Crohn's disease 1, 2
<250 mg/g: Most specific threshold (67% sensitivity, 73% specificity) - higher values strongly suggest active inflammation 1
Age-Specific Variations
Important caveat: Normal ranges vary significantly by age, particularly in young children:
- Infants 1-6 months: <538 mg/kg 3
- Children 6 months-3 years: <214 mg/kg 3
- Children 3-4 years: <75 mg/kg 3
- Children 1-3.9 years: <77 µg/g 4
- Children 4-17.9 years and adults: <62 µg/g 4
Children under 4 years have physiologically higher calprotectin levels, making adult cutoffs inappropriate for this population 4, 3.
Special Population Considerations
Pregnant women show slightly elevated reference intervals:
These values are higher than standard adult cutoffs, though the clinical significance remains uncertain 5.
Clinical Application Algorithm
For symptomatic remission in IBD patients:
- Fecal calprotectin <150 mg/g reliably rules out active inflammation, avoiding unnecessary endoscopy 1
- Values >150 mg/g warrant endoscopic assessment rather than empiric treatment 1, 2
For patients with mild symptoms:
- Even with calprotectin <150 mg/g, active inflammation cannot be ruled out - proceed to endoscopy 1
For primary care screening:
- Values <50 µg/g effectively exclude organic intestinal disease with 100% negative predictive value 6
- Values 50-150 µg/g represent an indeterminate zone requiring individualized assessment 7
- Values >150 µg/g warrant gastroenterology referral and endoscopy 7
Critical Pitfalls to Avoid
Do not use adult cutoffs in children under 4 years - this will result in false positives due to physiologically elevated baseline levels 4, 3.
Do not rely on elevated calprotectin alone in asymptomatic patients - in low pretest probability scenarios, elevated values have high false-positive rates (up to 36.6% for values >50 mg/g) 1. Repeat testing in 3-6 months is reasonable before proceeding to invasive assessment 1.
In older adults (≥50 years), calprotectin maintains high sensitivity (93.8%) but low positive predictive value (12.8%) for IBD 8. Consider combining with fecal immunochemical testing (FIT) when colorectal cancer is in the differential 8.
The 150 mg/g threshold represents the optimal balance between sensitivity and specificity for clinical decision-making in adult IBD patients, supported by the highest quality guideline evidence 1, 2.